{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:13:39Z","timestamp":1790273619702,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,1,29]],"date-time":"2013-01-29T00:00:00Z","timestamp":1359417600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-244x-13-39","type":"journal-article","created":{"date-parts":[[2013,1,29]],"date-time":"2013-01-29T04:45:07Z","timestamp":1359434707000},"source":"Crossref","is-referenced-by-count":24,"title":["Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit\/hyperactivity disorder"],"prefix":"10.1186","volume":"13","author":[{"given":"Greg W","family":"Mattingly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard H","family":"Weisler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Adeyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Dirks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Babcock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Lasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Scheckner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,29]]},"reference":[{"issue":"3","key":"1205_CR1","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S1056-4993(18)30106-8","volume":"9","author":"L Scahill","year":"2000","unstructured":"Scahill L, Schwab-Stone M: Epidemiology of ADHD in school-age children. Child Adolesc Psychiatr Clin N Am. 2000, 9 (3): 541-555. vii","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"issue":"4","key":"1205_CR2","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1176\/ajp.2006.163.4.716","volume":"163","author":"RC Kessler","year":"2006","unstructured":"Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, Faraone SV, Greenhill LL, Howes MJ, Secnik K, et al: The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006, 163 (4): 716-723. 10.1176\/appi.ajp.163.4.716.","journal-title":"Am J Psychiatry"},{"issue":"9","key":"1205_CR3","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.biopsych.2005.09.011","volume":"59","author":"J Biederman","year":"2006","unstructured":"Biederman J, Mick E, Surman C, Doyle R, Hammerness P, Harpold T, Dunkel S, Dougherty M, Aleardi M, Spencer T: A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit\/hyperactivity disorder. Biol Psychiatry. 2006, 59 (9): 829-835. 10.1016\/j.biopsych.2005.09.011.","journal-title":"Biol Psychiatry"},{"issue":"2","key":"1205_CR4","doi-asserted-by":"publisher","first-page":"268","DOI":"10.4088\/JCP.v68n0213","volume":"68","author":"U Jain","year":"2007","unstructured":"Jain U, Hechtman L, Weiss M, Ahmed TS, Reiz JL, Donnelly GA, Harsanyi Z, Darke AC: Efficacy of a novel biphasic controlled-release methylphenidate formula in adults with attention-deficit\/hyperactivity disorder: results of a double-blind, placebo-controlled crossover study. J Clin Psychiatry. 2007, 68 (2): 268-277. 10.4088\/JCP.v68n0213.","journal-title":"J Clin Psychiatry"},{"issue":"9","key":"1205_CR5","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.4088\/JCP.v69n0903","volume":"69","author":"LA Adler","year":"2008","unstructured":"Adler LA, Goodman DW, Kollins SH, Weisler RH, Krishnan S, Zhang Y, Biederman J, on behalf of the 303 study group: Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit\/hyperactivity disorder. J Clin Psychiatry. 2008, 69 (9): 1364-1373. 10.4088\/JCP.v69n0903.","journal-title":"J Clin Psychiatry"},{"issue":"8","key":"1205_CR6","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1017\/S1092852900013687","volume":"11","author":"RH Weisler","year":"2006","unstructured":"Weisler RH, Biederman J, Spencer TJ, Wilens TE, Faraone SV, Chrisman AK, Read SC, Tulloch SJ, on behalf of the SLI381.303 Study group: Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial. CNS Spectr. 2006, 11 (8): 625-639.","journal-title":"CNS Spectr"},{"issue":"3","key":"1205_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3810\/pgm.2008.09.1904","volume":"120","author":"L Culpepper","year":"2008","unstructured":"Culpepper L, Mattingly G: A practical guide to recognition and diagnosis of ADHD in adults in the primary care setting. Postgrad Med. 2008, 120 (3): 16-26. 10.3810\/pgm.2008.09.1904.","journal-title":"Postgrad Med"},{"issue":"6","key":"1205_CR8","doi-asserted-by":"publisher","first-page":"754","DOI":"10.4088\/JCP.08m04902pur","volume":"71","author":"SV Faraone","year":"2010","unstructured":"Faraone SV, Glatt SJ: A comparison of the efficacy of medications for adult attention-deficit\/hyperactivity disorder using meta-analysis of effect sizes. J Clin Psychiatry. 2010, 71 (6): 754-763. 10.4088\/JCP.08m04902pur.","journal-title":"J Clin Psychiatry"},{"key":"1205_CR9","volume-title":"ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation","author":"GJ DuPaul","year":"1998","unstructured":"DuPaul GJ, Power TJ, Anastopoulos AD, Reid R: ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation. 1998, New York, NY: Guilford Press"},{"issue":"9","key":"1205_CR10","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1001\/archpsyc.1991.01810330075011","volume":"48","author":"E Frank","year":"1991","unstructured":"Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Lavori PW, Rush AJ, Weissman MM: Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry. 1991, 48 (9): 851-855. 10.1001\/archpsyc.1991.01810330075011.","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"1205_CR11","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1399-5618.2009.00726.x","volume":"11","author":"M Tohen","year":"2009","unstructured":"Tohen M, Frank E, Bowden CL, Colom F, Ghaemi SN, Yatham LN, Malhi GS, Calabrese JR, Nolen WA, Vieta E, et al: The international society for bipolar disorders (ISBD) task force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord. 2009, 11 (5): 453-473. 10.1111\/j.1399-5618.2009.00726.x.","journal-title":"Bipolar Disord"},{"issue":"11","key":"1205_CR12","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1016\/j.clinthera.2006.11.006","volume":"28","author":"M Steele","year":"2006","unstructured":"Steele M, Jensen PS, Quinn DMP: Remission versus response as the goal of therapy in ADHD: a new standard for the field?. Clin Ther. 2006, 28 (11): 1892-1908. 10.1016\/j.clinthera.2006.11.006.","journal-title":"Clin Ther"},{"key":"1205_CR13","first-page":"218","volume-title":"ECDEU Assessment Manual for Psychopharmacology","author":"W Guy","year":"1976","unstructured":"Guy W: Clinical global impressions. ECDEU Assessment Manual for Psychopharmacology. 1976, Rockville, MD: US Department of Health, Education, and Welfare; Public Health Service, Alcohol, Drug Abuse and Mental Health Administration, NIMH Psychopharmacology Research Branch, 218-222."},{"issue":"3","key":"1205_CR14","first-page":"44","volume":"17","author":"D Goodman","year":"2010","unstructured":"Goodman D, Faraone SV, Adler LA, Dirks B, Hamdani M, Weisler R: Interpreting ADHD rating scale scores: linking ADHD rating scale scores and CGI levels in two randomized controlled trials of lisdexamfetamine dimesylate in ADHD. Primary Psychiatry. 2010, 17 (3): 44-52.","journal-title":"Primary Psychiatry"},{"issue":"5","key":"1205_CR15","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1176\/appi.ajp.157.5.816","volume":"157","author":"J Biederman","year":"2000","unstructured":"Biederman J, Mick E, Faraone SV: Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am J Psychiatry. 2000, 157 (5): 816-818. 10.1176\/appi.ajp.157.5.816.","journal-title":"Am J Psychiatry"},{"issue":"5","key":"1205_CR16","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1176\/ajp.155.5.646","volume":"155","author":"PE Keck Jr","year":"1998","unstructured":"Keck PE, McElroy SL, Strakowski SM, West SA, Sax KW, Hawkins JM, Bourne ML, Haggard P: 12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode. Am J Psychiatry. 1998, 155 (5): 646-652.","journal-title":"Am J Psychiatry"},{"key":"1205_CR17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1176\/appi.books.9780890423349","volume-title":"Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision","author":"American Psychiatric Association","year":"2000","unstructured":"American Psychiatric Association: Attention-deficit and disruptive behavior disorders. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. 2000, Washington, DC: American Psychiatric Association, 85-93."},{"issue":"2","key":"1205_CR18","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/00004583-200102000-00011","volume":"40","author":"JM Swanson","year":"2001","unstructured":"Swanson JM, Kraemer HC, Hinshaw SP, Arnold LE, Conners CK, Abikoff HB, Clevenger W, Davies M, Elliott GR, Greenhill LL, et al: Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry. 2001, 40 (2): 168-179. 10.1097\/00004583-200102000-00011.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"5","key":"1205_CR19","doi-asserted-by":"publisher","first-page":"e404","DOI":"10.1542\/peds.112.5.e404","volume":"112","author":"MA Stein","year":"2003","unstructured":"Stein MA, Sarampote CS, Waldman ID, Robb AS, Conlon C, Pearl PL, Black DO, Seymour KE, Newcorn JH: A dose\u2013response study of OROS methylphenidate in children with attention-deficit\/hyperactivity disorder. Pediatrics. 2003, 112 (5): e404-10.1542\/peds.112.5.e404.","journal-title":"Pediatrics"},{"issue":"10","key":"1205_CR20","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1017\/S1092852900024056","volume":"14","author":"R Weisler","year":"2009","unstructured":"Weisler R, Young J, Mattingly G, Gao J, Squires L, Adler L, on behalf of the 304 study group: Long-term safety and effectiveness of lisdexamfetamine dimesylate in adults with attention-deficit\/hyperactivity disorder. CNS Spectr. 2009, 14 (10): 573-585.","journal-title":"CNS Spectr"},{"key":"1205_CR21","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Statist Assn. 1958, 53: 457-481. 10.1080\/01621459.1958.10501452.","journal-title":"J Am Statist Assn"},{"key":"1205_CR22","volume-title":"Poster Present Am Psychiatr Assoc 162nd Annu Meeting","author":"J Young","year":"2009","unstructured":"Young J, Mattingly G, Weisler R, Squires L, Adeyi B, Dirks B, Babcock T, Scheckner B: Response and symptomatic remission in a long-term trial of lisdexamfetamine dimesylate in adults with attention-deficit\/hyperactivity disorder. Poster Present Am Psychiatr Assoc 162nd Annu Meeting. 2009, San Francisco, CA"},{"issue":"2","key":"1205_CR23","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s00406-008-0845-4","volume":"259","author":"M R\u00f6sler","year":"2009","unstructured":"R\u00f6sler M, Fischer R, Ammer R, Ose C, Retz W: A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit\/hyperactivity disorder. Eur Arch Psychiatry Clin Neurosci. 2009, 259 (2): 120-129. 10.1007\/s00406-008-0845-4.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"10","key":"1205_CR24","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.biopsych.2007.11.008","volume":"63","author":"R Medori","year":"2008","unstructured":"Medori R, Ramos-Quiroga JA, Casas M, Kooij JJ, Niemela A, Trott GE, Lee E, Buitelaar JK: A randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit\/hyperactivity disorder. Biol Psychiatry. 2008, 63 (10): 981-989. 10.1016\/j.biopsych.2007.11.008.","journal-title":"Biol Psychiatry"},{"issue":"5","key":"1205_CR25","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1177\/1087054708320397","volume":"12","author":"LA Adler","year":"2009","unstructured":"Adler LA, Spencer T, McGough JJ, Jiang H, Muniz R: Long-term effectiveness and safety of dexmethylphenidate extended-release capsules in adult ADHD. J Atten Disord. 2009, 12 (5): 449-459. 10.1177\/1087054708320397.","journal-title":"J Atten Disord"},{"issue":"2","key":"1205_CR26","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1001\/archpediatrics.2009.263","volume":"164","author":"JN Epstein","year":"2010","unstructured":"Epstein JN, Langberg JM, Lichtenstein PK, Altaye M, Brinkman WB, House K, Stark LJ: Attention-deficit\/hyperactivity disorder outcomes for children treated in community-based pediatric settings. Arch Pediatr Adolesc Med. 2010, 164 (2): 160-165. 10.1001\/archpediatrics.2009.263.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"1205_CR27","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s12618-009-0024-1","volume":"1","author":"E Sciberras","year":"2009","unstructured":"Sciberras E, Roos LE, Efron D: Review of prospective longitudinal studies of children with ADHD: mental health, educational, and social outcomes. Curr Atten Disord Report. 2009, 1: 1171-1177.","journal-title":"Curr Atten Disord Report"},{"key":"1205_CR28","volume-title":"Abstract presented at: American Psychiatric Association 161st Annual Meeting; May 3\u20138","author":"J Buitelaar","year":"2008","unstructured":"Buitelaar J, Wilens T, Zhang S, Ning Y, Feldman P: What level of ADHD symptom reduction is necessary for functional improvement?. Abstract presented at: American Psychiatric Association 161st Annual Meeting; May 3\u20138. 2008, Washington, DC: American Psychiatric Association, Abstract NR6-016"},{"key":"1205_CR29","volume-title":"DSM-5: The Future of Psychiatric Diagnosis","author":"American Psychiatric Association","year":"2012","unstructured":"American Psychiatric Association: DSM-5: The Future of Psychiatric Diagnosis. 2012, http:\/\/www.dsm5.org\/Pages\/Default.aspx . Accessed February 29, 2012"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-13-39.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-244X-13-39\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-13-39","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T20:02:56Z","timestamp":1562616176000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/1471-244X-13-39"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,29]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1205"],"URL":"https:\/\/doi.org\/10.1186\/1471-244x-13-39","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,29]]},"article-number":"39"}}